Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 3651-3700 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT07114718
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
NANot yet recruiting
35 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2028
2 conditions2 sponsors0 locations
NCT06864689
Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.
EARLY_PHASE1Not yet recruiting
78 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT05779930
Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
EARLY_PHASE1Not yet recruiting
12 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2035
6 conditions1 sponsor1 location
NCT07121010
How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses
NANot yet recruiting
15 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT07123454
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Not yet recruiting
91 participants
Started: Oct 31, 2025 · Completed: Mar 1, 2028
1 condition1 sponsor17 locations
NCT07124481
Early Mindfulness Based Cognitive Therapy for Prevention of Psychological Distress in Cancer Patients
NANot yet recruiting
208 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
2 conditions2 sponsors0 locations
NCT07073924
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
NANot yet recruiting
536 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2028
1 condition2 sponsors4 locations
NCT07115628
Accelerated TMS for Treatment-Resistant ECT
NARecruiting
200 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT07104110
Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer
PHASE1/PHASE2Not yet recruiting
50 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2028
1 condition1 sponsor0 locations
NCT07110038
DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
PHASE2Not yet recruiting
25 participants
Started: Oct 31, 2025 · Completed: Nov 30, 2030
1 condition4 sponsors1 location
NCT07196007
Leveraging Community-clinical Linkages to Address Unmet Social Needs for People With Diabetes
NANot yet recruiting
12,000 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2027
2 conditions2 sponsors1 location
NCT07123415
A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
PHASE1Not yet recruiting
110 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
2 conditions1 sponsor0 locations
NCT07197424
The Use of Robot Assisted Magnetically Controlled Capsule Endoscopy in Patients With Iron Deficiency Anaemia
NANot yet recruiting
100 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT06651528
Trauma-informed Intervention to Reduce Substance Use and to Support Community Transition
NANot yet recruiting
264 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2029
1 condition3 sponsors4 locations
NCT07118306
COPD Exacerbation Follow Up
N/ANot yet recruiting
485 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors0 locations
NCT07120087
Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.
NANot yet recruiting
1,508 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2027
1 condition2 sponsors2 locations
NCT07120568
Clinical Charactaristics , Risk Factors and Outcomes of Stroke in Pediatric Patients at Assiut University Children's Hospital
N/ANot yet recruiting
45 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT06822907
Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults
PHASE4Not yet recruiting
1,052 participants
Started: Oct 31, 2025 · Completed: Jan 1, 2028
2 conditions2 sponsors24 locations
NCT06364904
A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.
PHASE3Not yet recruiting
210 participants
Started: Oct 31, 2025 · Completed: Apr 15, 2029
1 condition1 sponsor8 locations
NCT07098273
Improving Hand Movement and Coordination in People With Multiple Sclerosis Using Transcranial Magnetic Stimulation (TMS) and Muscle Electrostimulation (FES) To Support Manual Dexterity and Daily Function
NANot yet recruiting
50 participants
Started: Oct 31, 2025 · Completed: May 31, 2027
1 condition2 sponsors2 locations
NCT07119970
Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)
NANot yet recruiting
300 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2030
2 conditions1 sponsor16 locations
NCT07077395
Finding Links Between Hot flASHes and CardioVascular Disease
PHASE2Not yet recruiting
80 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2030
1 condition1 sponsor2 locations
NCT07120490
STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection
NANot yet recruiting
424 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2027
6 conditions2 sponsors0 locations
NCT07161622
Comparing Low-Level Laser and Muscle Energy Techniques in Diabetic Frozen Shoulder
NANot yet recruiting
36 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2026
1 condition1 sponsor0 locations
NCT07181369
A Phase 1 Study of GTX-B001 in Healthy Subjets and Patients With Cold Urticaria
PHASE1Not yet recruiting
72 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2027
2 conditions1 sponsor2 locations
NCT07179679
A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
PHASE1Not yet recruiting
42 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor3 locations
NCT07179900
Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma
PHASE2Not yet recruiting
60 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2028
1 condition1 sponsor0 locations
NCT07119502
Implementation of a Minimal Equipment Exercise Intervention in Community-dwelling Older Adults With Dementia
NANot yet recruiting
50 participants
Started: Oct 31, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor0 locations
NCT07118033
Algo K Specific Manual Therapy for Sub Acute Low Back Pain With Radicular Symptoms
NANot yet recruiting
60 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor0 locations
NCT07048457
Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma
PHASE2Not yet recruiting
32 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2028
2 conditions2 sponsors1 location
NCT07085325
CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
N/ANot yet recruiting
184 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2031
1 condition1 sponsor1 location
NCT06904261
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
PHASE3Recruiting
8 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor7 locations
NCT06906367
A Study of Patients With Fabry Disease (US Specific)
N/ANot yet recruiting
450 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2032
1 condition1 sponsor4 locations
NCT07158398
Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 Substrate
PHASE1Recruiting
20 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT07165860
Clinical Trial to Reduce Perinatal Intimate Partner Violence
NANot yet recruiting
326 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2029
2 conditions2 sponsors3 locations
NCT07169851
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
PHASE2Not yet recruiting
204 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2026
4 conditions1 sponsor70 locations
NCT07217847
Testing SHAPE: A Single-Session Intervention Targeting Binge Eating in Women Through Assessment and Values-Based Strategies
NANot yet recruiting
56 participants
Started: Oct 31, 2025 · Completed: May 31, 2027
5 conditions2 sponsors1 location
NCT07217860
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
PHASE3Enrolling by invitation
400 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2029
4 conditions1 sponsor2 locations
NCT06810934
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
PHASE1/PHASE2Recruiting
80 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2029
2 conditions5 sponsors2 locations
NCT07098936
Momelotinib in VEXAS Syndrome
PHASE2Not yet recruiting
57 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2028
2 conditions2 sponsors11 locations
NCT06650839
POC for the Treatment of Subjects With Moderate AS Using Valvosoft® Non-Invasive Ultrasound Therapy
NANot yet recruiting
10 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2027
1 condition3 sponsors1 location
NCT07066436
ImmunoMRI for Assessment of Tumor-associated Macrophages
EARLY_PHASE1Not yet recruiting
60 participants
Started: Oct 31, 2025 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT07052305
NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Yescarta® (Axicabtagene Ciloleucel) or Post-Breyanzi® (Lisocabtagene Maraleucel) in Subjects With Relapsed/Refractory Large B-cell Lymphoma
PHASE1Not yet recruiting
24 participants
Started: Oct 31, 2025 · Completed: Apr 30, 2028
1 condition2 sponsors1 location
NCT06801145
The Effect of Video-Supported Education Provided to Patients Undergoing Open Heart Surgery Regarding the Intensive Care Process on Anxiety Levels and Intensive Care Experience
NANot yet recruiting
110 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT06594068
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
PHASE4Recruiting
16 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT07088978
Adaptation of the PROFFIT Instrument Into Turkish: A Validity and Reliability Study
N/ANot yet recruiting
320 participants
Started: Oct 31, 2025 · Completed: Feb 28, 2026
1 condition4 sponsors0 locations
NCT06682234
Study of Obeldesivir as Postexposure Prophylaxis for Filovirus Diseases Virus Disease
PHASE2Not yet recruiting
400 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2025
2 conditions1 sponsor0 locations
NCT07034794
A Clinical Trial to Examine Lysoveta on Cognitive Function in Healthy Adults With Self-perceived Memory Problems
NANot yet recruiting
138 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT07079969
Effects of Photobiomodulation and Topical Diclofenac on Inflammation and Pain in Knee Osteoarthritis (EPIC-KO)
PHASE2Not yet recruiting
32 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06926322
Evaluation of Different Medicaments in the Management of Necrotic Primary Molars by Lesion Sterilization and Tissue Repair
NAEnrolling by invitation
108 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2030
4 conditions1 sponsor1 location